Regeneron Pharmaceuticals reported $3.49B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agenus AGEN:US USD 208.35M 20.03M
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
Alimera Sciences ALIM:US USD 5.51M 2.34M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Amgen AMGN:US USD 9.3B 197M
Astellas Pharma 4503:JP JPY 361.07B 48.06B
AstraZeneca AZN:LN USD 4.46B 359M
Biogen BIIB:US USD 3.68B 1.03B
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Bristol Myers Squibb BMY:US USD 9.12B 1.39B
Esperion Therapeutics ESPR:US USD 159.4M 36.46M
Gilead Sciences GILD:US USD 7.63B 2.93B
GlaxoSmithKline GSK:LN GBP 3.72B 117M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
IONIS PHARMACEUT IONS:US USD 314.99M 206.92M
Kyowa Hakko Kirin 4151:JP JPY 332.78B 7.11B
Moderna Inc MRNA:US USD 3.03B 154M
Neurocrine Biosciences NBIX:US USD 212.2M 48.9M
Novartis NVS:US USD 7.52B 1.21B
Novartis NOVN:VX USD 8.73B 5.1B
Ophthotech OPHT:US USD 153.1M 11.99M
Opthea Ltd OPT:AU USD 32.78M 79.66M
Puma Biotechnology PBYI:US USD 77.96M 25.2M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Roche Holding ROG:VX 4.32B 2.54B
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Seattle Genetics SGEN:US USD 362.6M 2.27M
Teva Pharmaceutical TEVA:IT USD 2.22B 167M
Ultragenyx Pharmaceutical RARE:US USD 391.65M 231.78M
United Therapeutics UTHR:US USD 966.8M 171.6M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
YTE INCY:US USD 2.69B 255.24M